Biotech Values

[bladerunner1717]

Momenta Pharma (MNTA) Shares Sink as Amphastar Pharma Gets FDA Approval for Generic Lovenox -WSJ

More News related to MNTA

Momenta Pharma (MNTA) Shares Sink as Amphastar Pharma Gets FDA Approval for Generic Lovenox -WSJ


Momenta Pharma (MNTA) Shares Sink as Amphastar Pharma Gets FDA Approval for Generic Lovenox -WSJ
Prana (PRAN) Reports Publication of Positive Data for PBT2 on Restoring Cognitive Function in Alzheimer's Patients
Aastrom (ASTM) Reports Encouraging Results of IMPACT-DCM from 12-Month Follow Up
Marshall Edwards (MSHL) Doses First Patient in ME-143 Phase I
Adeona (AEN) Completes Enrollment in Trimesta Trial; Receives Additional Funding

More News related to FDA
September 19, 2011 11:18 AM EDT

Shares of Momenta Pharma (Nasdaq: MNTA) are plunging following a WSJ headline which reports Amphastar Pharma has received FDA approval for the generic version of Lovenox.

Bladerunner